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EPIDERMAL SENSITIZATION TO STREPTOMYCIN
REPORT OF Six CASES OCCURRING IN TWELVE
NURSES HANDLING THE DRUG*
MAURICE J. STRAUSS, M.D. AND FREDERICK C. WARRING, JR., M.D.
In a preliminary report published in this journal (1) we reported four cases
of contact dermatitis caused by streptomycin. In this communication we
present the detailed description of these patients and add to them two more
cases of sensitization due to the same drug. The similarity between strepto-
mycin and penicillin would lead one to expect that, since the latter is well known
to cause sensitization on local application, streptomycin might also be found
to cause contact dermatitis. Yet to the knowledge of the writers, there has
been no published report of such occurrence previous to our preliminary report.
It is true that penicillin has been widely used as a topical application while the
use of streptomycin has been almost completely limited to parenteral admin-
istration. On the other hand thc first reported case of contact dermatitis
from penicillin, reported by Pyle and Rattner (2), occurred in an army medical
officer who acquircd the dcrmatitis from handling the drug, not from using it
as a medication.
The six cases of sensitization which we report here all occurred in a group of
twelve nurses at the Laurel Heights Sanatorium. They came in contact with
streptomycin in the course of administering it to patients and rinsing out the
syringes.
CASE REPORTS
Case 1. R. C. began to give injections of streptomycin on November 11, 1946. About
one month later she first noticed itching and redness in the second interspace of the left
hand. This gradually spread and appeared on the other hand. About six weeks later an
eruption appeared on the eyelids. On March 25, 1947 she presented, on both hands, several
poorly defined erythematous plaques with minute papules and crusts. The lesions were
found on the extensor surface of the hands, the fingers, and in the finger webs. In the last
location there were also seen superficial fissures. The eyelids were somewhat swollen,
dusky, and scaly. The patient denied the use of nail polish, eyebrow pencil, or mascara.
Because the physicians at the sanatorium suspected that streptomycin might be the cause
of the eruption, the patient brought with her a vial containing a small amount of a solution
of that drug (lot no. 624). A patch test was done with this, in the usual manner, on the
flexor surface of the left forearm and also one on the V of the neck. The patches were re-
moved twenty-four hours later and the tcsts read forty-eight hours after removal. At that
time both areas showed erythema, edema, and vesiculation. Because the solution had run
out under the entire patch, a test was applied to the right forearm, using only adhesive and
cellophane. This caused no reaction. A second test was applied to the right forearm using
less of the solution. This showed, forty-eight hours after removal of the patch, a central
area of erythema, edema, and vesiculation. Each test was followed by a temporary flare-up
of the dermatitis. The patient was removed from contact with the drug, and boric acid
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ointment was applied. Within one week the eyelids returned to normal and the hands were
markedly improved.
FIG. 1. (CA5F 1) THE ERUPTION ON THE EyELIDS
Fic. 2. (CASE 1) THE DERMATITIS ON THE HAND
CGIC 2. A. M. hegan a similar exposure to streptomycin on November 11, 1946. About
three months later she first noticed an eruption on her fingers, followed in about three weeks
by its appearance in the right antecubital space, and in two weeks more by lesions on the
eyelids. The eruption was similar to that seen in Case 1. A patch test with a solution of
streptomycin taken from the same bottle as used in the previous case showed erytheina and
edema twenty-four and forty-eight hours after removal of the patch, and also caused a flare-
V
EPIDERMAL SENSITIZATION TO STREPTOMYCIN 101
up of the eruption. Treatment with boric acid ointment and the use of rubber gloves while
handling streptomycin resulted in complete disappearance of the eruption from the eyelids
and marked improvement in the condition on the antecubital spnces and the hands in the
course of one week.
Case 3. F. J. who began to administer streptomycin on November 11, 1946 noticed the
eruption on her fingers about three and a half months later and on the eyelids after another
week. A patch test with material from the same bottle of streptomycin showed erythema
FIG 3. DILUTIoN TESTS ON CASE I
Right—streptomycin calcium chloride complex.
Left—streptomycin hydrochloride, lot 647.
Reading from top to bottom in each column are dilutions 1:5, 1:10, 1:50, 1:100, 1:500, and1:1000. At the very bottom are the penicillin (right) and the tyrothricin (left) control
tests.
and edema at twenty-four and forty-eight hours after removal and caused a flare-up of the
original eruption. The use of boric acid ointment and rubber gloves caused rapid improve-
ment of the eruption.
Cuss 4. I. E. was a nurse with quiescent pulmonary tuberculosis. She was exposed to
solutions of streptomycin in the same manner as the preceding patients from November 11,
through February 10, at which time the status of her pulmonary disease made it necessary
for her to stop work and go to bed. One week before this she had noticed an eruption on
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her left hand, left antecubital space, and left eyelid, This eruption disappeared entirely
in one week after she ceased having any contact with streptomycin. At the time that the
patch tests were done there was no evidence of any eruption. A patch test with the same
solution of streptomycin was strongly positive.
FIG. 4. (CASE 1) SnowinG THE INTENSITY Of THE REACTION TO THE PATCIJ TEsTs
On the left arm from the top down the reactions are as follows: streptomycin hydrochlor-
ide, lot 624, applied March 25; streptomycin hydrochloride, lot 624, applied March 30;
streptomyein calcium chloride complex, applied March 30; streptomycin hydrochloride,lot 647, applied March 30. On the right arm the reaction is to strcptomycin hydrochloride,
lot 624, applied March 28. Just above this is the site of the control test with adhesive and
cellophane, applied March 28. Photograph taken on April 17.
SUPPLEMENTARY PATCH TESTS
When the first tests were done on patient R. 0. and found to be strongly
positive it was felt that it should be definitely established that streptomycin in
such dilution (1 gm. in 5 ml.) is not a primary irritant. Patch tests were done,
with material from the same vial, on four normal individuals who had never
had any contact with streptomycin. All these tests were completely negative.
In order to rule out the possibility that the reactions were due to an impurity
in the streptomycin a second series of tests were performed using streptomycin
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hydrochloride from two different lots (nos. 624 and 647) and also a solution of
streptomycin calcium chloride complex' prepared in the same manner as the
streptomycin hydrochloride (1 gm. dissolved in 5 ml. of sterile distilled water).
The subjects used for this series of tests were the twelve nurses whose skin
had been previously exposed to the drug. Seven of these, including the four
TABLE I
24 hours after
removal
48 hours after
removal
Lot 624
CaCI, Comp.
Lot 647
Lot 624
CaC1I Comp.
Lot 647
FREQUENT EXPOSURE OCCASIONAL EXPOSURE
R.G.
Case
1
3+
3+
3+
3+
3+
3+
A.M.
Case
2
3+
3+
1+
2+
2+
2+
F.J.
Case
3
1+
1+
1+
2+
2+
2+
I.E.
Case
4
3+
2+
2+
3+
3+
2+
H.H.
No
rash
0
0
0
0
0
0
MB.
No
rash
0
0
0
0
0
0
MR.
No
rash
1+
2+
1+
1+
2+
1+
GA.
No
rash
0
3+
1+
1+
2+
2+
AK.
No
rash
0
0
0
0
0
0
S.D.
No
rash
0
0
0
0
0
0
M.M.
No
rash
0
0
0
0
0
0
SR.
No
rash
0
0
0
0
0
0
1+ = erythema.
2+ erythema and papulee.
3+ = erythema and edema.
TABLE II
SIJBJXCT
R. G.
Case 1.
I)ILTJTION
S. HC1
S. CaC1,
1:5
3+
3+
1:10
3+
3+
1:50
1+
3+
1:100
1+
3+
1:500
1+
1+
1:1000
1+
1+
A.M.
Case 2.
S.HC1
S. CaC1,
3+
3+
3+
3+
1+
3+
1+
1+
0
1+
0
0
F. J.
Case 3.
S. HCI
S. CaC1,
3+
3+
3+
3+
1+
1+
1+
1+
0
0
0
0
I. E.
Case 4.
S. HC1
S. CaCI,
3+
3+
3+
3+
2+
2+
1+
0
0
0
0
0
M. R. S. HCI
S. CaCI2
3+
3+
3+
3+
1+
1+
1+
1+
1+
1+
0
0
G. A. S. HC1
S. CaC1,
3+
3+
3+
3+
1+
2+
1+
2+
0
0
0
0
1+ = Erythema.2+ = Erythema and Papules.
3+ = Erythema and Edema.
with dermatitis, could be said to have had frequent contact with streptomycin.
Five had had only occasional contact with the drug. The results of these tests
are shown in table I.
1 Streptomycin trihydrochioride calcium chloride complex is a white powder of high pu-
rity and of uniform potency—i .37 grams being equivalent to 1 gram of streptomycin base.
This was furnished by Merck and Co., Inc., Rahway, N. J.
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Patch tests with increasing dilutions were done to determine the point at
which reaction no longer existed. Streptomycin hydrochloride (lot 647) and
streptomyein calcium chloride complex were used in the following dilutions: 1
to 5, 1 to 10, 1 to 50, 1 to 100, 1 to 500, and 1 to 1000. In addition, as controls,
two other antibiotics were used. These were crystalline sodium penicillin
(10,000 units in 1 ml. of sterile distilled water) and tyrothricin (1 mg. in 1 gm.
of ointment base). In order to make the tests as uniform as possible each one
was done with four drops of the solution delivered from a 27 gauge hypodermic
needle. The subjects were the six patients who had given positive reactions to
streptomyein in previous tests. Table II shows the results of the tests with
streptomyein solutions. The tests with penicillin and tyrothricin were nega-
tive in all cases.
cOMMENT
The fact that the dermatitis was caused by the streptomycin in all four
eases seems to have been definitely established. The eruption appeared at
intervals varying from one month to three and a half months after the beginning
of exposure to the drug. All four patients showed unequivocally positive results
to patch tests to streptomyein, and in all four the eruption disappeared promptly
when exposure to streptomyein was avoided. The possibility that strepto-
mycin, in the concentration used, is a primary irritant must he dismissed since
it failed to produce a reaction not only in four individuals who had never been
exposed to streptomycin but also in six who had had varying degrees of ex-
posure to it.
The two subjects M. R. and G. A. who, although they never had any eruption,
demonstrated sensitivity to streptomycin upon patch testing, demonstrate
more clearly and forcibly the potentialities of this drug as a sensitizer. Despite
the fact that they had not as yet developed clinical evidence of acquired sensi-
tivity it is evident that they had become sensitized to streptomycin. Sulzberger
(3) has stated that: "Whenever a reaction of eezcmatous character is produced
at the site of the application of the patch, provided a substance has been used
which is not a primary irritant, one may conclude that eezematous hyper-
sensitiveness of the skin to this substance has been demonstrated." We believe
that ample evidence has been presented that streptomycin is not a primary
irritant. The apparent paradox of a positive patch test without clinical disease
has also been referred to by Sulzbcrgcr (4). The two subjects showing this
phenomenon are of importance from two points of view. First, they increase
the number of individuals sensitized to streptomycin to six out of twelve. While
no statistically valid conclusions can be drawn from a series of only twelve
individuals, it nevertheless suggests that the index of epidermal sensitization
to this drug may prove to he high. Secondly, it is quite possible that if these
two subjects continued their exposure to streptomycin clinical symptoms would
develop. For this reason they were instructed to wear rubber gloves when
haadling the drug, as were the patients with clinical dermatitis.
With no previous reports of sensitization to this drug available, it is perhaps
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of interest to give consideration to the early reports of epidermal sensitivity to
penicillin. Of particular interest are three reports in which the patients came
in contact with penicillin in its preparation or administration just as the four
patients reported here came in contact with streptomycin. Pyle and Rattner's
(2) patient reacted not only to crude amorphous penicillin but also to crystalline
penicillin; Binkley and Brockmole 's (5) patient who showed a positive patch
test to sodium penicillin was not tested with crystalline penicillin; and Silvers'
(6) patient reacted to a patch test with yellow amorphous penicillin but did
not react when tested with crystalline penicillin. The last of these makes it
quite evident that in considering cases of sensitization to the antibiotics the
possibility that sensitization is caused by an impurity rather than by the drug
itself should be investigated. The question of whether the patients reported
by us were sensitive to impurities in the drug or to streptomycin itself was
definitely answered by the series of tests in which not only two different lots of
the drug were used but also a preparation containing 98% (7) or more of strep-
tomycin. Reference to table I shows no essential difference in the results
obtained in the six individuals who reacted positively. The patients tested
were either positive to all three test materials or to none at all. It therefore
seems likely that the six subjects who gave positive reactions were sensitive to
the streptomyein itself. As would be expected, most of the sensitized individ-
uals were found in the group frequently exposed to the drug rather than in the
group only occasionally exposed. It is impossible to measure the exact amount
of exposure because of individual differences in technic. We have divided our
patients into two groups, based upon the number and frequency of exposures.
The first group, seven in number, administered from 15 to 25 doses of strepto-
mycin six days out of each week. This we considered frequent exposure. The
second, or occasionally exposed group, were five in number. These were ex-
posed to streptomyein only once a week. Five of the seven subjects frequently
exposed to the drug demonstrated sensitivity. Only one of the five occasionally
exposed showed evidence of sensitization. Sensitization in this one case is
worthy of note because it again demonstrates the well known fact that individual
variations are of importance in the development or lack of development of an
acquired sensitivity.
In R. 0., the patient showing the most marked clinical evidence of sensitiza-
tion, there was a definite reaction to patch tests with a streptomycin dilution
of 1 to 1000 although this reaction was weaker than that to the lesser dilution.
In the other five eases there was a striking similarity in the reaction produced
by the different dilutions (table II). The first negative test appeared with a
dilution of 1 to 100 and only two showed any reaction in a dilution of 1 to 500.
A dilution of 1 to 5 failed to elicit any reaction in six individuals who had been
more or less exposed to streptomyein as well as four who had had no such ex-
posure. It would seem, therefore, that patch tests for epidermal sensitivity
to streptomycin should be carried out with a solution of one gm. of the dnig in
50 ml. of distilled water. It is also of interest to note that two other anti-
biotics, penicillin and tyrothriein, failed to elicit any reaction in the six individ-
uals sensitive to streptomycin.
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CONCLUSION
Four eases of clinical epidermal sensitization to streptomyein are reported in
detail.
There were two further eases of subclinical, but demonstrable (by patch
test) sensitization.
All of these occurred in a group of twelve nurses coming in contact with
streptomycin in the course of administering the drug to patients.
The sensitivity appears to be due to streptomycin itself rather than to any
impurity in the drug.
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